205
Participants
Start Date
February 28, 2009
Primary Completion Date
December 31, 2015
Study Completion Date
December 31, 2015
Placebo
Clinical evaluation, patient reported outcome questionnaires, photographs, caliper measurements and recording adverse events
ATX-101 (1 mg/cm^2)
Clinical evaluation, patient reported outcome questionnaires, photographs, caliper measurements and recording adverse events
ATX-101 (2 mg/cm^2)
Clinical evaluation, patient reported outcome questionnaires, photographs, caliper measurements and recording adverse events
ATX-101 (4 mg/cm^2)
Clinical evaluation, patient reported outcome questionnaires, photographs, caliper measurements and recording adverse events
Mei-Heng Tan, Sydney
T/AS Dermatology Institute of Victoria, South Yarra
Southeast Dermatology Belmont Specialist Centre, Carina Heights
Skin Centre, AHC House, Benowa
Total Skin & Beauty Dermatology Center, Birmingham
Minnesota Clinical Study Center, Fridley
Dermatology Institute of DuPage Medical Group in Naperville, Naperville
Body Aesthetic Research Center, St Louis
Skin Specialists, PC, Omaha
Research Across America, Plano
Clinical Testing Center Beverly Hills, Beverly Hills
Mokusiga, Inc, Beverly Hills
Plastic & Reconstructive Surgery, San Francisco
Skin Care Physicians, Chestnut Hill
Niagara Falls Dermatology & Skin Care, Niagara Falls
Institute of Cosmetic & Laser Surgery, Oakville
Toronto Cosmetic Skin Surgery Centre, Toronto
Cosmetic Dermatology on Bloor, Toronto
The Dermatology Centre, Salford
Cranley Clinic, Harcout House, London
Lead Sponsor
Kythera Biopharmaceuticals
INDUSTRY